1,5-Naphthyridine azolinone
    13.
    发明授权
    1,5-Naphthyridine azolinone 失效
    1,5-萘啶氮杂酮

    公开(公告)号:US07268231B2

    公开(公告)日:2007-09-11

    申请号:US11244022

    申请日:2005-10-05

    申请人: Jin-Jun Liu

    发明人: Jin-Jun Liu

    IPC分类号: C07D471/02

    CPC分类号: C07D471/04

    摘要: 1,5-Naphthyridine azolinone derivatives are disclosed. These compounds are inhibitors of CDK1 and are useful as antiproliferative agents, such as anti-cancer agents.

    摘要翻译: 公开了1,5-萘啶的唑啉酮衍生物。 这些化合物是CDK1的抑制剂,可用作抗增生剂,如抗癌剂。

    1,5-naphthyridine azolinone
    15.
    发明申请
    1,5-naphthyridine azolinone 失效
    1,5-二氮杂萘唑啉酮

    公开(公告)号:US20060084673A1

    公开(公告)日:2006-04-20

    申请号:US11244022

    申请日:2005-10-05

    申请人: Jin-Jun Liu

    发明人: Jin-Jun Liu

    IPC分类号: C07D471/02 A61K31/4745

    CPC分类号: C07D471/04

    摘要: 1,5-Naphthyridine azolinone derivatives are disclosed. These compounds are inhibitors of CDK1 and are useful as antiproliferative agents, such as anti-cancer agents.

    摘要翻译: 公开了1,5-萘啶氮杂酮衍生物。 这些化合物是CDK1的抑制剂,可用作抗增生剂,如抗癌剂。

    Spiroindolinone derivatives
    19.
    发明授权
    Spiroindolinone derivatives 失效
    螺吲哚啉酮衍生物

    公开(公告)号:US07495007B2

    公开(公告)日:2009-02-24

    申请号:US11846597

    申请日:2007-08-29

    IPC分类号: A61K31/438 C07D471/10

    CPC分类号: C07D471/10

    摘要: The present invention relates to spiroindolinone derivatives of the formula and their enantiomers and pharmaceutically acceptable salts and esters thereof wherein R1, R2, R3, R4, R5, R6, R7 and R8, are as herein described. The compounds have utility as antiproliferative agents, especially, as anticancer agents.

    摘要翻译: 本发明涉及下式的螺二吲哚啉酮衍生物及其对映异构体及其药学上可接受的盐和酯,其中R 1,R 2,R 3,R 4,R 5,R 6,R 7和R 8如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。